DG

Damini Gupta

Active Director Director DIN 08349953
DIN 08349953 First appointment Feb 2019 Primary industry Healthcare
Unlock full profile Investments · shareholding · contact details
Current companies 1 active board seats
Total affiliations 1 Since Feb 2019
Shareholding value •••• Premium profile

About Damini Gupta

Data last updated:

Damini Gupta is a Director at Veloce Herbals Private Limited (since 2019). The company operates in Healthcare. Veloce Herbals Private Limited reported revenue of ₹8.18 Cr (FY 2025).

DIN 08349953
Primary Designation Director
Industry Healthcare
First Appointment 01 Feb 2019
Oldest Company Age 7 yrs
Largest company Veloce Herbals Private Limited · ₹8.18 Cr (FY 2025)

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Veloce Herbals Private Limited U15549MP2019PTC047686
Director01 Feb 20192019₹8.18 Cr (FY 2025)Active

Board colleagues of Damini Gupta

NameDINCompanyDesignation
Nitin Gupta07299757Veloce Herbals Private LimitedDirector

Directorship timeline

Open interactive timeline →
Veloce Herbals Private Limited
Premium access

Shareholding and investment profile for Damini Gupta

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Damini Gupta

Damini Gupta currently holds 1 directorship: Veloce Herbals Private Limited (Director, since 01 Feb 2019, revenue ₹8.18 Cr (FY 2025)).

Damini Gupta was first appointed on 01 Feb 2019 as Director at Veloce Herbals Private Limited.

The current boards of Damini Gupta's companies include Nitin Gupta (Veloce Herbals Private Limited).

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available